3
Announcements
Trials
Browse
Landscape
Phase
Phase 4
1
Status
Completed
1
Sponsor Class
OTHER
1
Study Type
Interventional
1
Sponsor
Cancer Type
Classical hematology
1
Conditions
Leukemia, Myeloid, Acute
25
Breast Neoplasms
14
Neoplasms
12
Myelodysplastic Syndromes
12
Prostatic Neoplasms
10
Multiple Myeloma
8
Lung Neoplasms
7
Stomach Neoplasms
6
Sarcoma
6
Ovarian Neoplasms
5
Leukemia, Myelomonocytic, Chronic
5
Recurrence
4
Neoplasm Metastasis
4
Lymphoma, Non-Hodgkin
4
Head and Neck Neoplasms
4
Colorectal Neoplasms
4
Carcinoma, Non-Small-Cell Lung
4
Advanced Solid Tumor
4
Uterine Cervical Neoplasms
3
Squamous Cell Carcinoma of Head and Neck
3
Solid Tumor
3
Small Cell Lung Carcinoma
3
Pain
3
Mucositis
3
Lymphoma, T-Cell, Peripheral
3
Cholangiocarcinoma
3
Carcinoma, Transitional Cell
3
Carcinoma, Hepatocellular
3
Stomatitis
2
Skin Neoplasms
2
Interventions
pegylated granulocyte colony-stimulating factor
3
pegfilgrastim
3
Vancomycin
3
Interleukin 1 Receptor Antagonist Protein
2
Filgrastim
2
Ceftazidime
2
Cefepime
2
Amikacin
2
Vaccination
1
Teicoplanin
1
Tazobactam
1
Surveys and Questionnaires
1
Sodium Chloride
1
Positron Emission Tomography Computed Tomography
1
Pneumococcal Vaccines
1
Piperacillin
1
N,N'-bis(pyridoxal-5-phosphate)ethylenediamine-N,N'-diacetic acid
1
Meropenem
1
Linezolid
1
Itraconazole
1
Injections
1
Cloxacillin
1
Ciprofloxacin
1
Cilastatin, Imipenem Drug Combination
1
Bevacizumab
1
Anti-Bacterial Agents
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Completed
×
Febrile Neutropenia
×
Injections
×
Clear all
NCT04948463
2026-03-20
ELSA-FN
Murdoch Childrens Research Institute
Phase 4
Completed
55 enrolled